Integrated Plasma Proteomics and Functional Analyses Reveal Hepatic CDHR2 as a Potential Therapeutic Target in MASLD.

Key Points

• The study aims to investigate CDHR2's role in the development and progression of MASLD.
• Utilized integrated plasma proteomics
• Conducted functional analyses
• Focused on hepatic tissues and biomarkers
• Identified CDHR2 as a novel regulator of MASLD
• Highlighted the potential of CDHR2 as a therapeutic target for treatment